Home
Conditions
Hematologic Malignancies

Clinical trial condition

Hematologic Malignancies

Explore clinical trials studying Hematologic Malignancies. Study availability and eligibility vary by location and protocol.

134 public trials 30 recruiting studies

Refine in advanced search Browse all conditions

Hematologic Malignancies trial results

Completed

Tacrolimus, Sirolimus and Methotrexate as Graft Versus Host Disease Prophylaxis After Blood Stem Cell Transplantation

NCT00146614

Conditions: Graft Versus Host Disease, Graft vs Host Disease, Hematologic Diseases, +6 more
Locations: Beth Isreal Deaconess Medical Center Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Completed

Phase I/II Trial of Fludarabine Plus Busulfan and Allogeneic Progenitor Cell Support

NCT00506857

Conditions: Hematologic Diseases, Hematologic Malignancies, Hematologic Neoplasms, +11 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Related Stem Cell Transplantation

NCT00144703

Conditions: Acute Lymphoblastic Leukemia, Bone Marrow Diseases, Graft vs Host Disease, +23 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

IUdR/BUdR Cell Cycle Labelling

NCT00042250

Conditions: Hematologic Diseases, Hematologic Malignancies, Hematologic Neoplasms, +3 more
Locations: M.D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Safety Study of MultiStem® in Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplasia

NCT00677859

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +12 more
Locations: Mayo Clinic Hospital Phoenix, Arizona, United States

University Hospitals Case Medical Center Cleveland, Ohio, United States

Oregon State University Medical Center Portland, Oregon, United States

University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Nonmyeloablative Stem Cell Transplantation With CD8-depleted or Unmanipulated Peripheral Blood Stem Cells (PBSC)

NCT00693927

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +17 more
Locations: CHU Sart Tilman Liège, Liege, Belgium

View Trial Details

Completed

Conditioning Regimen Before Infusion of Allogeneic Hematopoietic Stem Cells

NCT00770523

Conditions: Hematologic Diseases, Hematologic Malignancies, Hematologic Neoplasms, +3 more
Locations: Asan Medical Center Seoul, South Korea

View Trial Details

Completed

Darbepoetin Alfa (Aranesp) Following Allogeneic Stem Cell Transplantation

NCT00355407

Conditions: Hematologic Diseases, Hematologic Malignancies, Hematologic Neoplasms, +3 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Trial of Prophylactic Versus Empirical Vancomycin for the Prevention of Streptococcal Sepsis After Hematopoietic Cell Transplantation

NCT00138112

Conditions: Hematologic Diseases, Hematologic Malignancies, Hematologic Neoplasms, +4 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Active, Not Recruiting

Giving Chemotherapy for a Shortened Amount of Time Before a Stem Cell Transplantation

NCT04098393

Conditions: Hematologic Diseases, Hematologic Malignancies, Hematologic Neoplasms, +3 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Hematologic Malignancies

Hematologic Malignancies trial results

Related conditions